Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
364-02-003 ISMRM Abstract

Characterization of radiation-induced changes in healthy mice brain using CEST MRI at 9.4 T

Primary: Contrast Mechanisms - CEST / APT / NOE
Secondary: Neuro - Tumors
364-02-003 · Innovations in Brain Tumor Imaging: Quantitative MRI, Radiogenomics, and Deep-Learning Approaches · Monday, 11 May, 9:15 AM–10:10 AM · Digital Posters Row E
Keywords: Radiotherapy Small animals 9.4T CEST MRI Neuro-Oncology
Accepted
Florian Kroh 1,2, Anika Simon3,4, Markus Alber3,4, Sebastian Regnery3,4,5, Jürgen Debus3,4,5, Armin Lühr6, Mark E Ladd1,5,7, Andreas Korzowski1,7, Daniel Paech2,8, Julia Bauer3,4,5,9, Philip S Boyd1
1Division of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
2Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America
3Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
4Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
5Faculty of Medicine, Heidelberg University, Heidelberg, Germany
6Department of Physics, TU Dortmund University, Dortmund, Germany
7Faculty of Physics and Astronomy, Heidelberg University, Heidelberg, Germany
8Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
9Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Presenting Author: Florian Kroh

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Ou A, Alfred Yung WK, Majd N. Molecular Mechanisms of Treatment Resistance in Glioblastoma. International Journal of Molecular Sciences 2021, Vol 22, Page 351. 2020;22(1):351. doi:10.3390/IJMS22010351 [doi]
2. Ellingson BM, Chung C, Pope WB, Boxerman JL, Kaufmann TJ. Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol. 2017;134(3):495-504. doi:10.1007/S11060-017-2375-2 [doi]
3. Wen PY, Van Den Bent M, Youssef G, et al. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. Journal of Clinical Oncology. 2023;41(33):5187-5199. doi:10.1200/JCO.23.01059 [doi]
4. Zhou J, Zaiss M, Knutsson L, et al. Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors. Magn Reson Med. 2022;88(2):546-574. doi:10.1002/MRM.29241 [doi]
5. Boyd PS, Breitling J, Korzowski A, et al. Mapping intracellular pH in tumors using amide and guanidyl CEST-MRI at 9.4 T. Magn Reson Med. 2022;87(5):2436-2452. doi:10.1002/MRM.29133 [doi]
6. Kroh F, von Knebel Doeberitz N, Breitling J, et al. Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy. Magn Reson Med. 2023;90(4):1569-1581. doi:10.1002/MRM.29746 [doi]
7. Liu J, Li C, Chen Y, et al. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T. Journal of Magnetic Resonance Imaging. 2020;51(4):1154-1161. doi:10.1002/JMRI.26900 [doi]
8. Park YW, Ahn SS, Kim EH, et al. Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters. Neuroradiology. 2021;63(3):363-372. doi:10.1007/S00234-020-02542-5/FIGURES/5 [doi]
9. Besuglow J, Echner G, Mairani A, Alber M, Bahn E. EP-1938 A high precision irradiation system for in vivo RBE measurements with ion beams. Radiotherapy and Oncology. 2019;133:S1055-S1056. doi:10.1016/s0167-8140(19)32358-8 [doi]
10. Schuenke P, Windschuh J, Roeloffs V, Ladd ME, Bachert P, Zaiss M. Simultaneous mapping of water shift and B1(WASABI)—Application to field-Inhomogeneity correction of CEST MRI data. Magn Reson Med. 2017;77(2):571-580. doi:10.1002/MRM.26133 [doi]
11. Windschuh J, Zaiss M, Meissner JE, et al. Correction of B1-inhomogeneities for relaxation-compensated CEST imaging at 7T. NMR Biomed. 2015;28(5):529-537. doi:10.1002/NBM.3283 [doi]
12. Zaiss M, Xu J, Goerke S, et al. Inverse Z-spectrum analysis for spillover-, MT-, and T1-corrected steady-state pulsed CEST-MRI - application to pH-weighted MRI of acute stroke. NMR Biomed. 2014;27(3):240-252. doi:10.1002/NBM.3054 [doi]
13. Goerke S, Zaiss M, Kunz P, et al. Signature of protein unfolding in chemical exchange saturation transfer imaging. NMR Biomed. 2015;28(7):906-913. doi:10.1002/NBM.3317 [doi]
14. Zaiss M, Kunz P, Goerke S, Radbruch A, Bachert P. MR imaging of protein folding in vitro employing Nuclear-Overhauser-mediated saturation transfer. NMR Biomed. 2013;26(12):1815-1822. doi:10.1002/NBM.3021 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/364-02-003